Mercy Clinic Oncology and Hematology
Oklahoma City, Oklahoma, United States
Cancer treatment center in Oklahoma City, Oklahoma
4401 McAuley Blvd Suite 2700, Oklahoma City, OK 73120
About Mercy Clinic Oncology and Hematology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Mercy Clinic Oncology and Hematology
During the past decade, Mercy Clinic Oncology and Hematology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
1996-01-01
Unknown status
300
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
2000-05-19
2010-01-27
Completed
3,436
Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
2000-12-01
2014-11-01
Terminated
748
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
2002-09-01
Completed
1,734
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
2001-10-18
Active, not recruiting
1,449
Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures
2002-07-01
2005-02-01
Completed
3,000
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
2002-01-01
Completed
45
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mercy Clinic Oncology and Hematology" #1 sponsor was "Novartis Pharmaceuticals" with 2 trials, followed by "Helsinn Healthcare SA" with 1 trials
sponsored, "Inivata" with 1 trials sponsored, "Mirati Therapeutics Inc." with 1 trials sponsored and "Northwestern University"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Clinic Oncology and Hematology"
#1 collaborator was "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Guardian Research Network, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Mercy Clinic Oncology and Hematology
According to Clinical.Site data, the most researched conditions in "Mercy Clinic Oncology and Hematology" are
"Acute Myeloid Leukemia" (1 trials), "Advanced or Metastatic Gastric or Gastroesophageal Cancer" (1 trials), "Advanced or Metastatic Solid Tumor" (1 trials), "Advanced, Metastatic Breast Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Mercy Clinic Oncology and Hematology" in a lesser frequency.
Clinical Trials Intervention Types at Mercy Clinic Oncology and Hematology
Most popular intervention types in "Mercy Clinic Oncology and Hematology" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (1 trials), "Capecitabine" (1 trials), "Docetaxel" (1 trials), "Futibatinib" (1 trials) and "LDK378" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mercy Clinic Oncology and Hematology
The vast majority of trials in "Mercy Clinic Oncology and Hematology" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Mercy Clinic Oncology and Hematology
Currently, there are NaN active trials in "Mercy Clinic Oncology and Hematology".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Mercy Clinic Oncology and Hematology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Mercy Clinic Oncology and Hematology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".